Federal Supply Schedule V797D70182

Award Date 7/1/17
Last Date to Order 6/30/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), provides for the delivery of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $174,737,620.00 and a period of performance through March 31, 2028. The prime contractor for this multiple award contract is Kowa Pharmaceuticals America Inc., a for-profit manufacturer of goods. The contract does not utilize any set-asides. The scope of the contract encompasses a...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Viiv Healthcare Company, a foreign-owned for-profit manufacturer. The contract, valued at a ceiling of $1,870,730,000.00, is for the delivery of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from August 15, 2021, to August 14, 2026. This is a multiple-award contract, with no set-aside...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
The Federal Supply Schedule contract award referenced is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSS Contract 65 I B) by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 12. The prime contractor is Haleon US LP, a for-profit manufacturer of goods. The contract has a total ceiling value of $9,867,650.00 and a period of performance extending through September 30, 2026. This is a multiple award schedule contract, meaning it...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Verity Pharmaceuticals, Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB schedule, with a contract ceiling value of $225,000.00 and a period of performance through November 30, 2026. The...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Mycovia Pharmaceuticals, Inc., is for the provision of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $22,500.00 and a period of performance running until February 29, 2028. As a Federal Supply Schedule contract, this is a multiple-award vehicle that allows federal agencies to purchase the specified products and...

This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Covis Pharmaceuticals, Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a total ceiling value of $1,132,470.00 and a period of performance extending through June 30, 2026.

As a multiple award Federal Supply Schedule contract, this vehicle enables the VA and other federal agencies to procure the specified pharmaceutical and drug products and services from Covis Pharmaceuticals, which is a self-certified small disadvantaged business. The contract does not utilize any set-asides. The scope of contracted products and services can be further discerned from the master schedule and any associated task orders or price lists, though these details were not provided in the information given.

Generated 7/3/25, 2:55 PM